Last $15.01 USD
Change Today -0.23 / -1.51%
Volume 269.4K
INFI On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:10 PM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - infinity pharmaceuticals inc (INFI)

Name (Connections)Board RelationshipsTitleKey Developments
Anthony Evnin Ph.D. 142 RelationshipsDirector, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee 
Ian Smith CPA, ACA 52 RelationshipsDirector and Chairman of Audit Committee 
Norman Selby 117 RelationshipsLead Outside Director, Chairman of Compensation Committee and Member of Audit Committee 

Compensation Committee* - infinity pharmaceuticals inc (INFI)

Name (Connections)Board RelationshipsTitle
Norman Selby 117 RelationshipsLead Outside Director, Chairman of Compensation Committee and Member of Audit Committee
INFI Compensation vs. Industry
552.0K
362.1K
Chief Executive Officer
378.8K
268.0K
Chief Financial Officer
Share price activity for INFINITY PHARMACEUTICALS INC (INFI)
52 Week Price Performance
INFI
Industry Average

Nominating Committee* - infinity pharmaceuticals inc (INFI)

Name (Connections)Board RelationshipsTitleKey Developments
Anthony Evnin Ph.D. 142 RelationshipsDirector, Chairman of Nominating & Corporate Governance Committee and Member of Audit CommitteeInfinity Pharmaceuticals, Inc. Announces Board Changes
03/10/14
Eric Lander Ph.D. 54 RelationshipsIndependent Director, Member of Nominating & Corporate Governance Committee and Member of Research & Development CommitteeInfinity Pharmaceuticals, Inc. Promotes David Roth to Chief Medical Officer
02/15/14
Gwen Fyfe M.D. 37 RelationshipsIndependent Director, Member of Nominating & Corporate Governance Committee and Member of Research & Development CommitteeInfinity Pharmaceuticals, Inc. Announces Promotion of David A. Roth to Chief Medical Officer
02/4/14

Corporate Governance Committee* - infinity pharmaceuticals inc (INFI)

Name (Connections)Board RelationshipsTitle
Anthony Evnin Ph.D. 142 RelationshipsLead Outside Director, Chairman of Compensation Committee and Member of Audit Committee
Gwen Fyfe M.D. 37 Relationships--
Eric Lander Ph.D. 54 Relationships--
INFI and Competitor
Insiders vs. External
Board
11%
89%
Infinity Pharmaceuticals, Inc.
9%
91%
Array BioPharma, Inc.
15%
85%
CTI BioPharma Corp.
15%
85%
Exelixis, Inc.
0%
100%
Evotec AG
0%
100%
GlaxoSmithKline S.A.E
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INFI:US $15.01 USD -0.23

INFI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Array BioPharma Inc $4.03 USD +0.08
CTI BioPharma Corp $2.19 USD -0.04
Evotec AG €3.23 EUR -0.023
Exelixis Inc $1.66 USD -0.10
GlaxoSmithKline SAE £12.94 EGP 0.00
View Industry Companies
 

Industry Analysis

INFI

Industry Average

Valuation INFI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.6x
Price/Book 3.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INFINITY PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.